Three different CRISPR-mediated KO methods, including “CRISPR excision,“ “CRISPR HDR,“ and “CRISPR du-HITI,“ were used to change the position of NOX4 in several breast cancer cell lines. This evidence concerns the gene NOX4 and breast carcinoma.